Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1994 Feb;49(2):104–106. doi: 10.1136/thx.49.2.104

Antibiotic penetration into lung tissues.

D Honeybourne
PMCID: PMC474317  PMID: 8128396

Full text

PDF
104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abd A. G., Nierman D. M., Ilowite J. S., Pierson R. N., Jr, Bell A. L., Jr Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis. Chest. 1988 Aug;94(2):329–331. doi: 10.1378/chest.94.2.329. [DOI] [PubMed] [Google Scholar]
  2. Aldons P. M. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):101–108. doi: 10.1093/jac/27.suppl_a.101. [DOI] [PubMed] [Google Scholar]
  3. Anderson G., Esmonde T. S., Coles S., Macklin J., Carnegie C. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):117–124. doi: 10.1093/jac/27.suppl_a.117. [DOI] [PubMed] [Google Scholar]
  4. Aubert-Tulkens G., Van Hoof F., Tulkens P. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study. Lab Invest. 1979 Apr;40(4):481–491. [PubMed] [Google Scholar]
  5. Azoulay-Dupuis E., Vallée E., Bedos J. P., Muffat-Joly M., Pocidalo J. J. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. Antimicrob Agents Chemother. 1991 Jun;35(6):1024–1028. doi: 10.1128/aac.35.6.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baldwin D. R., Andrews J. M., Wise R., Honeybourne D. Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens. J Antimicrob Chemother. 1992 Sep;30(3):377–385. doi: 10.1093/jac/30.3.377. [DOI] [PubMed] [Google Scholar]
  7. Baldwin D. R., Wise R., Andrews J. M., Ashby J. P., Honeybourne D. Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J. 1990 Sep;3(8):886–890. [PubMed] [Google Scholar]
  8. Baldwin D. R., Wise R., Andrews J. M., Ashby J. P., Honeybourne D. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa. Eur Respir J. 1992 Apr;5(4):471–476. [PubMed] [Google Scholar]
  9. Baldwin D. R., Wise R., Andrews J. M., Gill M., Honeybourne D. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration. Respir Med. 1993 Nov;87(8):595–601. doi: 10.1016/s0954-6111(05)80262-8. [DOI] [PubMed] [Google Scholar]
  10. Baldwin D. R., Wise R., Andrews J. M., Honeybourne D. Quantitative morphology and water distribution of bronchial biopsy samples. Thorax. 1992 Jul;47(7):504–507. doi: 10.1136/thx.47.7.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barza M., Cuchural G. General principles of antibiotic tissue penetration. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):59–75. doi: 10.1093/jac/15.suppl_a.59. [DOI] [PubMed] [Google Scholar]
  12. Bergogne-Berezin E. Penetration of antibiotics into the respiratory tree. J Antimicrob Chemother. 1981 Sep;8(3):171–174. doi: 10.1093/jac/8.3.171. [DOI] [PubMed] [Google Scholar]
  13. Bergogne-Berezin E. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review). Infection. 1987 Jul-Aug;15(4):288–294. doi: 10.1007/BF01644140. [DOI] [PubMed] [Google Scholar]
  14. Bergogne-Bérézin E., Berthelot G., Even P., Stern M., Reynaud P. Penetration of ciprofloxacin into bronchial secretions. Eur J Clin Microbiol. 1986 Apr;5(2):197–200. doi: 10.1007/BF02013986. [DOI] [PubMed] [Google Scholar]
  15. Bradburne R. M., Ettensohn D. B., Opal S. M., McCool F. D. Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis. Thorax. 1989 Jul;44(7):591–593. doi: 10.1136/thx.44.7.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Carbon C., Léophonte P., Petitpretz P., Chauvin J. P., Hazebroucq J. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia. Antimicrob Agents Chemother. 1992 Apr;36(4):833–839. doi: 10.1128/aac.36.4.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carlier M. B., Zenebergh A., Tulkens P. M. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J Antimicrob Chemother. 1987 Nov;20 (Suppl B):47–56. doi: 10.1093/jac/20.suppl_b.47. [DOI] [PubMed] [Google Scholar]
  18. Chastre J., Brun P., Fourtillan J. B., Soler P., Basset G., Manuel C., Trouillet J. L., Gibert C. Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic. Antimicrob Agents Chemother. 1987 Sep;31(9):1312–1316. doi: 10.1128/aac.31.9.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cohen G. M. Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ Health Perspect. 1990 Apr;85:31–41. doi: 10.1289/ehp.85-1568313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cooper M. A., Andrews J. M., Ashby J. P., Matthews R. S., Wise R. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. J Antimicrob Chemother. 1990 Nov;26(5):667–676. doi: 10.1093/jac/26.5.667. [DOI] [PubMed] [Google Scholar]
  21. Dautzenberg B., Truffot C., Legris S., Meyohas M. C., Berlie H. C., Mercat A., Chevret S., Grosset J. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):564–569. doi: 10.1164/ajrccm/144.3_Pt_1.564. [DOI] [PubMed] [Google Scholar]
  22. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ferrero J. L., Bopp B. A., Marsh K. C., Quigley S. C., Johnson M. J., Anderson D. J., Lamm J. E., Tolman K. G., Sanders S. W., Cavanaugh J. H. Metabolism and disposition of clarithromycin in man. Drug Metab Dispos. 1990 Jul-Aug;18(4):441–446. [PubMed] [Google Scholar]
  24. Fraschini F., Scaglione F., Pintucci G., Maccarinelli G., Dugnani S., Demartini G. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):61–65. doi: 10.1093/jac/27.suppl_a.61. [DOI] [PubMed] [Google Scholar]
  25. Hand W. L., Corwin R. W., Steinberg T. H., Grossman G. D. Uptake of antibiotics by human alveolar macrophages. Am Rev Respir Dis. 1984 Jun;129(6):933–937. doi: 10.1164/arrd.1984.129.6.933. [DOI] [PubMed] [Google Scholar]
  26. Hand W. L., King-Thompson N. L. Membrane transport of clindamycin in alveolar macrophages. Antimicrob Agents Chemother. 1982 Feb;21(2):241–247. doi: 10.1128/aac.21.2.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Honeybourne D., Andrews J. M., Ashby J. P., Lodwick R., Wise R. Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa. Thorax. 1988 Sep;43(9):715–719. doi: 10.1136/thx.43.9.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Honeybourne D., Baldwin D. R. The site concentrations of antimicrobial agents in the lung. J Antimicrob Chemother. 1992 Sep;30(3):249–260. doi: 10.1093/jac/30.3.249. [DOI] [PubMed] [Google Scholar]
  29. Hughes D. T. The use of combinations of trimethoprim and sulphonamides in the treatment of chest infections. J Antimicrob Chemother. 1983 Nov;12(5):423–434. doi: 10.1093/jac/12.5.423. [DOI] [PubMed] [Google Scholar]
  30. Ilowite J. S., Gorvoy J. D., Smaldone G. C. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis. 1987 Dec;136(6):1445–1449. doi: 10.1164/ajrccm/136.6.1445. [DOI] [PubMed] [Google Scholar]
  31. Ingold A. Sputum and serum levels of amoxycillin in chronic bronchial infections. Br J Dis Chest. 1975 Jul;69:211–216. doi: 10.1016/0007-0971(75)90082-0. [DOI] [PubMed] [Google Scholar]
  32. Klastersky J., Carpentier-Meunier F., Kahan-Coppens L., Thys J. P. Endotracheally administered antibiotics for gram-negative bronchopneumonia. Chest. 1979 May;75(5):586–591. doi: 10.1378/chest.75.5.586. [DOI] [PubMed] [Google Scholar]
  33. Klastersky J., Geuning C., Mouawad E., Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest. 1972 Feb;61(2):117–120. doi: 10.1378/chest.61.2.117. [DOI] [PubMed] [Google Scholar]
  34. Le Conte P., Potel G., Peltier P., Horeau D., Caillon J., Juvin M. E., Kerguéris M. F., Bugnon D., Baron D. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis. 1993 May;147(5):1279–1282. doi: 10.1164/ajrccm/147.5.1279. [DOI] [PubMed] [Google Scholar]
  35. Marlin G. E., Davis P. R., Rutland J., Berend N. Plasma and sputum erythromycin concentrations in chronic bronchitis. Thorax. 1980 Jun;35(6):441–445. doi: 10.1136/thx.35.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Marlin G. E., Nicholls A. J., Funnell G. R., Bradbury R. Penetration of cefaclor into bronchial mucosa. Thorax. 1984 Nov;39(11):813–817. doi: 10.1136/thx.39.11.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. O'Doherty M., Thomas S., Page C., Bradbeer C., Nunan T., Bateman N. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. Thorax. 1990 Jun;45(6):460–464. doi: 10.1136/thx.45.6.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pascual A., Garcia I., Perea E. J. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1989 May;33(5):653–656. doi: 10.1128/aac.33.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pennington J. E. Penetration of antibiotics into respiratory secretions. Rev Infect Dis. 1981 Jan-Feb;3(1):67–73. doi: 10.1093/clinids/3.1.67. [DOI] [PubMed] [Google Scholar]
  40. Pennington J. E., Reynolds H. Y. Concentrations of gentamicin and carbenicillin in bronchial secretions. J Infect Dis. 1973 Jul;128(1):63–68. doi: 10.1093/infdis/128.1.63. [DOI] [PubMed] [Google Scholar]
  41. Prokesch R. C., Hand W. L. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982 Mar;21(3):373–380. doi: 10.1128/aac.21.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Retsema J. A., Girard A. E., Girard D., Milisen W. B. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):83–89. doi: 10.1093/jac/25.suppl_a.83. [DOI] [PubMed] [Google Scholar]
  43. Schentag J. J. Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet. 1989;16 (Suppl 1):25–31. doi: 10.2165/00003088-198900161-00005. [DOI] [PubMed] [Google Scholar]
  44. Schönwald S., Skerk V., Petricevic I., Car V., Majerus-Misic L., Gunjaca M. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):877–880. doi: 10.1007/BF01975847. [DOI] [PubMed] [Google Scholar]
  45. Staehelin L. A. Structure and function of intercellular junctions. Int Rev Cytol. 1974;39:191–283. doi: 10.1016/s0074-7696(08)60940-7. [DOI] [PubMed] [Google Scholar]
  46. Stamey T. A., Fair W. R., Timothy M. M., Millar M. A., Mihara G., Lowery Y. C. Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med. 1974 Nov 28;291(22):1159–1163. doi: 10.1056/NEJM197411282912204. [DOI] [PubMed] [Google Scholar]
  47. Stewart S. M., Fisher M., Young J. E., Lutz W. Ampicillin levels in sputum, serum, and saliva. Thorax. 1970 May;25(3):304–311. doi: 10.1136/thx.25.3.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tamaoki J., Isono K., Sakai N., Kanemura T., Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J. 1992 Feb;5(2):234–238. [PubMed] [Google Scholar]
  49. Tulkens P. M. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):100–106. doi: 10.1007/BF01964420. [DOI] [PubMed] [Google Scholar]
  50. Vadakekalam J., Ward M. J. Mycobacterium fortuitum lung abscess treated with ciprofloxacin. Thorax. 1991 Oct;46(10):737–738. doi: 10.1136/thx.46.10.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vallée E., Azoulay-Dupuis E., Pocidalo J. J., Bergogne-Bérézin E. Pharmacokinetics of four fluoroquinolones in an animal model of infected lung. J Antimicrob Chemother. 1991 Dec;28 (Suppl 100):39–44. doi: 10.1093/jac/28.suppl_c.39. [DOI] [PubMed] [Google Scholar]
  52. Vogels M. T., van der Meer J. W. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother. 1992 Jan;36(1):1–5. doi: 10.1128/aac.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Walters E. H., Gardiner P. V. Bronchoalveolar lavage as a research tool. Thorax. 1991 Sep;46(9):613–618. doi: 10.1136/thx.46.9.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wilson R., Read R., Cole P. Interaction of Haemophilus influenzae with mucus, cilia, and respiratory epithelium. J Infect Dis. 1992 Jun;165 (Suppl 1):S100–S102. doi: 10.1093/infdis/165-supplement_1-s100. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES